Detalhe da pesquisa
1.
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
J Pathol
; 253(2): 234-245, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140857
2.
p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.
Proc Natl Acad Sci U S A
; 112(45): 13916-21, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512117
3.
STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context.
Int J Mol Sci
; 19(9)2018 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30231553
4.
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
NPJ Breast Cancer
; 10(1): 5, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184660
5.
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
EMBO Mol Med
; 16(5): 1162-1192, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658801
6.
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
Nat Commun
; 14(1): 6777, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880212
7.
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.
Front Oncol
; 12: 891580, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35712501
8.
The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response.
Wiley Interdiscip Rev RNA
; 12(6): e1659, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951281
9.
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.
Cell Death Dis
; 12(10): 951, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654798
10.
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
EMBO Mol Med
; 13(7): e12872, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062049
11.
Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
Oncogene
; 39(40): 6370-6386, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32848212
12.
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Cancer Res
; 80(5): 1064-1077, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862778
13.
p27kip1 at the crossroad between actin and microtubule dynamics.
Cell Div
; 14: 2, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30976290
14.
Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis.
Cancer Res
; 79(2): 397-409, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478213
15.
Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Front Endocrinol (Lausanne)
; 9: 393, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30065701
16.
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Cancer Commun (Lond)
; 43(7): 844-849, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337406
17.
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
Nat Commun
; 14(1): 7129, 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932286
18.
Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells.
Sci Rep
; 7(1): 595, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377607
19.
Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer.
Aging (Albany NY)
; 8(5): 958-76, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27155197
20.
p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.
Oncotarget
; 7(40): 64560-64574, 2016 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27579539